ReviewThe Journal of international medical research2025
Primary hepatic follicular dendritic cell sarcoma: A case study and literature review.
Review in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular dendritic cell sarcoma, a rare malignant tumor arising from specialized antigen-presenting cells, typically occurs in lymph nodes but can also develop at extranodal sites, including the liver. We present a case of a woman in her late 20s with systemic lupus erythematosus who presented with fever as the chief complaint. Imaging revealed a hepatic mass, and pathology confirmed the diagnosis of hepatic follicular dendritic cell sarcoma. The patient showed no recurrence 1 year post-radical surgery. We analyzed a total of 43 cases from 32 previous reports and the present case. Among these, the mean age at onset was 48 years, the median maximum tumor diameter was 87.5 mm, and there was a female predominance. Survival analysis showed that the 5-year disease-free survival of patients was 63.4%. This case and literature review highlight the rarity and diagnostic challenges of primary hepatic follicular dendritic cell sarcoma, especially in patients with atypical presentations such as fever of unknown origin. Early recognition and radical surgery are crucial for a favorable prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.